Home
Resources
Diseases
Training
SYSVAC
About
Registry
E-learning courses
News
Events
Network
Vision and Mission
Steering Committee
Map
Meetings
Join us
Home
Resources
Resources
Selected
COVID-19
Influenza
Meningococcal disease
2021
2015
Americas
Clear all
Type of publications
NITAG documentation
(74)
Systematic reviews (SYSVAC)
(4)
Topics
Available to download in languages
Regions
Americas
(78)
Africa
(20)
Europe
(88)
South-East Asia
(2)
Western Pacific
(17)
Countries
Argentina
(1)
Bolivia
(2)
Canada
(20)
Chile
(9)
United States of America
(46)
Diseases
COVID-19
(64)
Influenza
(8)
Meningococcal disease
(6)
Diphtheria
(1)
Ebola
(1)
Hepatitis A
(1)
Human papillomavirus (HPV)
(12)
Pneumococcal disease
(1)
Rotavirus
(4)
Typhoid
(1)
Yellow fever
(3)
Vaccine topics
Acceptance
(1)
Coverage
(1)
Ethical issues
(2)
Safety
(1)
Target population
Adults
(2)
All age groups
(3)
Children
(3)
Healthcare workers
(1)
Older adults
(1)
Parents/caregivers
(1)
Pregnant women
(5)
Publication date
2021
(65)
2015
(13)
2024
(1)
2023
(14)
2022
(42)
2020
(67)
2019
(10)
2018
(8)
2017
(4)
2016
(22)
2014
(14)
2013
(4)
2012
(3)
2011
(5)
2010
(5)
2009
(7)
2008
(2)
2007
(3)
2006
(4)
2005
(1)
1997
(1)
78 results found
2015
∙
Jessica MacNeil
Considerations for Use of Serogroup B Meningococcal (MenB) Vaccines in Persons at Increased Risk
2015
∙
ACIP, Lisa Grohskopf, Sonja Olsen, Joseph Bresee, Leslie Sokolow, Karen Broder, Ruth Karron
Prevention and Control of Influenza with Vaccines
2015
∙
Lisa Grohskopf, Sonja Olsen, Joseph Bresee, Leslie Sokolow
Prevention and Control of Seasonal Influenza with Vaccines
2015
∙
Lisa Grohskopf
Proposed Recommendations2015-16 InfluenzaSeason
2015
∙
Kathleen Coelingh
Update on Live Attenuated Influenza Vaccine (LAIV)
2015
∙
Brendan Flannery, Jessie Clippard
Updated interim influenza vaccine effectiveness estimates by age group and vaccine type for the 2014-15 season: Updates from the US Influenza Vaccine Effectiveness (Flu VE) Network
2015
Use of Serogroup B Meningococcal Vaccines in Adolescents and Young Adults
2015
∙
Temitope Folaranmi, Lorry Rubin, Stacey W. Martin, Manisha Patel, Jessica MacNeil
Use of Serogroup B Meningococcal Vaccines in Persons Aged ≥10 Years at Increased Risk for Serogroup B Meningococcal Disease
Home
Resources
Diseases
Training
SYSVAC
News
Events
Network
Sign in / Register